Brain penetration of intrathecal iomeprol in dogs

Acta Radiologica

Volumn 37, Issue 4, 1996, Pages 578-581

  La Noce, A ^a   Lorenzon, P ^a   Pugliese, F ^b   Pellecchi, G ^b   Orlandini, I ^c   Tirone, P ^a  

^a Bracco SpA   (Italy)

^b Hospital of Mantova   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Brain penetration, myelography; CT, contrast media; Experimental comparison; Iomeprol

Indexed keywords

CONTRAST MEDIUM; DRUG DERIVATIVE; IOMEPROL; IOPAMIDOL;

ANIMAL; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN STEM; DOG; FEMALE; INTRASPINAL DRUG ADMINISTRATION; METABOLISM;

ANIMALS; BRAIN; BRAIN STEM; CEREBRAL CORTEX; CONTRAST MEDIA; DOGS; FEMALE; INJECTIONS, SPINAL; IOPAMIDOL;

EID: 0030191502     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859609175448     Document Type: Article

References (18)

1. BOOTH N. H. & MCDONALD L. E.: Farmacologia e terapeutica veterinaria. Edited by C. Beretta. E. M. SI., Rome 1991.
2. BRADBURY M.: The concept of a blood-brain barrier. John Wiley, Chichester 1979.
3. DRAYER B. P. & ROSENBAUM A. E.: Metrizamide brain penetrance. Acta Radiol. Suppl. 355 (1977), 280.
4. ELKIN C. M., LEVAN A. M. & LEEDS N. E.: Tolerance of iohexol, iopamidol and metrizamide in lumbar myelography. Surg. Neurol. 26 (1986), 542.
5. FIIRGARD M., MADSEN H. H. T., SVARE U., ERIKSEN F. B., SKIØDT T. & ZEEBERG I.: Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording. Acta Radiol. 36 (1995), 77.
6. HARRISH P. P. & DISTEFANO V.: Decreased cerebrospinal fluid production by intravenous sodium diatrizoate. Invest. Radiol. 19 (1984), 318.
7. KERBER C. W., SOVAK M., RANGANATHAN R. S. & HEILMAN C. B.: Iotrol, a new myelographic agent. I. Radiography, CT, CSF clearance, and brain penetration. AJRN 4 (1983), 317.
8. KIEFFER S. A., BINET E. F. & DAVIS D. O.: Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study. Invest. Radiol. Suppl. 20 (1985), 522.
9. LA NOCE A., BERTANI F., LORUSSO V., LUZZANI F., TIRONE P. & DE HAËN C.: Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. Eur. J. Radiol. 18 (1994), Suppl. 1, S43.
10. LA NOCE A., DANIELI A., BERTANI F., TIRONE P. & DE HAËN C.: Conditioned taste aversion in rats following intrathecal administration of contrast media. Acta Radiol 37 (1996), 116.
11. MOSCHINI L., MANARA O., BONALDI G., CASSINARI R., QUILICI N. & BELLONI G.: Iopamidol and metrizamide in cervical myelography. Side effects, EEG, and CSF changes. AJNR 4 (1982), 848.
12. OLDENDORF W. H. & DAVSON H.: Brain extracellular space and the sink action of the cerebrospinal fluid. Arch. Neurol. 17 (1967), 196.
13. SAGE M. R. & WILCOX J.: Brain parenchyma penetration by intrathecal nonionic iopamidol. AJRN 4 (1983), 1181.
14. SAGE M. R., WILCOX J., EVILL C. A. & BENNESS G. T.: Brain parenchyma penetration by intrathecal ionic and nonionic contrast media. AJRN 3 (1982), 481.
15. SHENG K. L., Moss A. A. & RIEGELMAN S.: Saturation kinetics of iodipamide. Invest. Radiol. 12 (1977), 175.
16. SOVAK M., DEUTSCH J. A. & RANGANATHAN R.: Evaluation of intrathecal contrast media by aversion conditioning in rats. Invest. Radiol. 17 (1982), 101.
17. SOVAK M., RANGANATHAN R. & JOHNSON M.: Spectral analysis of lapine EEG. Neurotoxicologic evaluation of new nonionic contrast media. Invest. Radiol. 15 (1980), 452.
18. WOOD A. K. W., KUNDEL H. L., MCGRATH J. T. & WORTMAN J. A.: Computed tomography, magnetic resonance imaging, and pathologic observations of the effects of intrathecal metrizamide and iohexol on the canine central nervous system. Invest. Radiol. 22 (1987), 672.